ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Xolair 300 mg/2 ml, Injektionslösung in einer Fertigspritze - 
68030003 Novartis Pharma Schweiz AG
Xolair 300 mg/2 ml, Injektionslösung in einer Fertigspritze08.04.2021
  03.07.2024
Omalizumab (R03DX05) 
WHO-DDD07.04.2026
03.04.50. 
03.04.50. 
B  
Yes 
IP 
751.66Yes
    
10 %833.90
7680680300039Biotechnologika
  
Composition
omalizumabum 300.00 mg, arginini hydrochloridum, histidini hydrochloridum monohydricum, histidinum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 2.00 ml.
Packungsbestandteile
Injection solution in prefilled syringe 
  
 
Active AgentDose
Omalizumab300mg / 2ml
BAG: Active AgentDose
Omalizumab300 mg
 
Inactive agents
Arginine Hydrochloride
Histidin Hydrochloride Monohydrate
Histidine
Polysorbatum 20
 
Source
Data was imported : 07.08.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home